Ligand validation:7BY9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7BY9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BY9_NAD_D_400	60%	42%	0.143	0.927	1.19	1.07	2	4	2	0	100%	1
7BY9_NAD_B_400	56%	37%	0.15	0.921	0.85	1.59	1	6	4	0	100%	1
7BY9_NAD_C_400	46%	47%	0.172	0.908	0.75	1.28	2	5	2	0	100%	1
7BY9_NAD_A_400	40%	53%	0.171	0.882	0.59	1.2	-	3	1	0	100%	1
7F8D_NAD_C_400	71%	53%	0.132	0.953	0.89	0.92	2	3	0	0	100%	1
7X1L_NAD_B_400	67%	49%	0.145	0.953	0.92	1.03	2	5	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.